Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19

• Главные авторы: Jingjing Li (Автор), Kai Zhang (Автор), Di Wu (Автор), Lianjie Ren (Автор), Xinyu Chu (Автор), Chao Qin (Автор), Xiaopeng Han (Автор), Taijun Hang (Автор), Yungen Xu (Автор), Lei Yang (Автор), Lifang Yin (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2021-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Strong infectivity enables coronavirus disease 2019 (COVID-19) to rage throughout the world. Moreover, the lack of drugs with definite therapeutic effects further aggravates the spread of the pandemic. Remdesivir is one of the most promising anti-severe acute respiratory syndrome coronavirus 2 (SARS...